EGFR / HER1 / ErbB1 Neutralizing Antibody sinobiological 10001-RE10

$286.00
In stock
SKU
10001-RE10
Catalog No.SizePrice (USD)
10001-RE10-200200 µg$296.22
10001-RE10-500500 µg$444.33

General Information

Product nameEGFR / HER1 / ErbB1 Neutralizing Antibody
Validated applicationsNeutralization
Species reactivityReacts with: Human
SpecificityHuman EGFR Has cross-reactivity in ELISA with Mouse EGFR (Catalog # 51091-M08H) Rat EGFR (Catalog # 80100-R08H) Rhesus EGFR (Catalog # 90317-K08H)
ImmunogenRecombinant Human EGFR / HER1 / ErbB1 Protein (Catalog#10001-H08H)
PreparationThis antibody was obtained from a rabbit immunized with purified, recombinant Human EGFR / HER1 / ErbB1 (rh EGFR / HER1 / ErbB1; Catalog#10001-H08H; NP_005219; Met1-Ser645) and was produced using recombinant antibody technology.
SourceMonoclonal Rabbit IgG Clone #RE10
PurificationProtein A
Formulation0.2 μm filtered solution in Histidine and Arginine buffer containing 120mM NaCl, 0.02% Tween 80, pH6.0
ConjugateUnconjugated
Endotoxin< 3 EU/mg
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageThis antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Synonyms: Anti-ERBB Antibody; Anti-ERBB1 Antibody; Anti-ERRP Antibody; Anti-HER1 Antibody; Anti-mENA Antibody; Anti-NISBD2 Antibody; Anti-PIG61 Antibody

Image / Experimental Information

Image 1 DescriptionCell Proliferation Induced by Autocrine EGF was Neutralized by Human EGFR Antibody. Autocrine EGF stimulates proliferation in the human breast cancer MDA-MB-468 cell line. Proliferation elicited by Autocrine EGF is neutralized by increasing concentrations of Human EGFR Monoclonal Antibody (Catalog # 10001-RE10). The IC50 is typically 0.05-0.2 μg/mL.
Image 1 Alt TextHuman EGFR/HER1 Blocking/Neutralization (B/N) 5602
Image 1 URLSource image

Background Information

Full Nameepidermal growth factor receptor
DescriptionAs a member of the epidermal growth factor receptor (EGFR) family, EGFR protein is type I transmembrane glycoprotein that binds a subset of EGF family ligands including EGF, amphiregulin, TGF-α, betacellulin, etc. EGFR protein plays a crucial role in signaling pathway in the regulation of cell proliferation, survival and differentiation. Binding of a ligand induces EGFR protein homo- or heterodimerization, the subsequent tyrosine autophosphorylation and initiates various down stream pathways (MAPK, PI3K/PKB and STAT). In addition, EGFR signaling also has been shown to exert action on carcinogenesis and disease progression, and thus EGFR protein is proposed as a target for cancer therapy currently.
Research Areas
  • Cancer Drug Targets
  • Receptor Tyrosine Kinases (RTKs)
Related Pathways
  • EGFR Signaling Pathway
  • Jak-Stat Signaling Pathway
Tags
  • Cancer Immunotherapy
  • Immune Checkpoint
  • Immunotherapy
  • Targeted Therapy
References
  1. Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases. Cell 103(2): 211-25.
  2. Giaccone, G. (2005) HER1/EGFR-targeted agents: predicting the future for patients with unpredictable outcomes to therapy. Ann. Oncol. 16(4): 538-48.
  3. Yarden, Y., et al. (2001) Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2(2): 127-37.

Reviews

Write Your Own Review
You're reviewing:EGFR / HER1 / ErbB1 Neutralizing Antibody sinobiological 10001-RE10
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.